Cardiovascular risk factors prevalence among patients with dyslipidemia in Colombia;Prevalencia de factores de riesgo cardiovascular en pacientes con dislipidemia afiliados al sistema de salud en colombia

Revista Peruana de Medicina Experimental y Salud Publica

Volumn 30, Issue 2, 2013, Pages 205-211

  Machado Alba, Jorge E ^a,b   Machado Duque, Manuel E ^a  

^a UNIVERSIDAD TECNOLÓGICA DE PEREIRA   (Colombia)

^b NONE

Author keywords

Cardiovascular diseases; Dyslipidemias; Hypercholesterolemia; Risk factors

Indexed keywords

ANTILIPEMIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COLOMBIA; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HEART DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COLOMBIA; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84882672700     PISSN: 17264634     EISSN: 17264642     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. World Health Organization, United Nations. What is the deadliest disease in the world? [Internet]. Geneva: WHO; c2013 [citado el 15 noviembre del 2012]. Disponible en: http://www.who.int/features/qa/18/en/index.html
2. Lurán A, López E, Pinilla C. Situación de la mortalidad por enfermedades cardiovasculares en seis regiones de Colombia, 1996-2005. Inf Quinc Epidem Nac. 2008;13(13):177-203.
3. León Latre M, Andre&s EM, Cordero A, Pascual I, Vispec C, Laclaustrad M, et al. Relationship between metabolic syndrome and ischemic heart disease mortality in Spain. Rev Esp Cardiol. 2009;62(12):1469-72.
4. 4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA. 2001;285(19):2486-97.
5. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet. 2005;366(6461):1059-62.
6. Guías de prevención primaria en riesgo cardiovascular. Tópicos selectos. Revista Colombiana de Cardiología. 2009;16 (Supl 3):71-192.
7. Truett J, Cornfield J, Kannel W. A multivariate analysis of risk of coronary heart disease in Framingham. J Chronic Dis. 1967;20(7):511-24.
8. Wilson PW, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 1987;59(14):91G-94G.
9. Grover SA, Lowensteyn I. The challenges and benefits of cardiovascular risk assessment in clinical practice. Can J Cardiol. 2011;27(4):481-7.
10. Brotons C, Cascant P, Ribera A, Moral I, Permanyer G. Utilidad de la medición del riesgo coronario a partir de la ecuación del estudio de Framingham: estudio de casos y controles. Med Clin (Barc). 2003;121(9):327-30.
11. Masson W, Siniawski D, Krauss J, Cagide A. Aplicabilidad clínica de la función de Framingham a 30 años. Utilidad en la estratificación del riesgo cardiovascular y en el diagnóstico de placa aterosclerótica carotídea. Rev Esp Cardiol. 2011;64(4):305-11.
12. Wu JY, Duan XY, Li L, Dai F, Li YY, Li XJ, et al. Dyslipidemia in Shanghai, China. Prev Med. 2010;51(5):412-5.
13. Gu SJ, Liu MM, Guo ZR, Wu M, Chen Q, Zhou ZY, et al. Gene-gene interactions among PPARα/δ/γ polymorphisms for hypertriglyceridemia in Chinese Han population. Gene. 2013;515(2):272-6.
14. Shimabukuro M, Chinen I, Higa N, Takasu N, Yamakawa K, Ueda S. Effects of dietary composition on postprandial endothelial function and adiponectin concentrations in healthy humans: a crossover controlled study. Am J Clin Nutr. 2007;86(4):923-8.
15. Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Clin Ther. 2007;29(8):1671-81.
16. Laforest L, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E. Mixed dyslipidemias in primary care patients in France. Vasc Health Risk Manag. 2012;8:247-54.
17. Barrios V, Martinez M, Tomas JP. Clinical profile of a hypercholesterolemic Spanish population and differences between genders. LIPYCARE study. Hipertensión. 2004;21(8):395-402.
18. Saldarriaga CI, Franco G, Garzón AM, García I, Mejía N, Restrepo A. Factores de riesgo para la enfermedad coronaria temprana en mujeres. Biomedica. 2010;30(4):559-66
19. Mendivil CO, Sierra ID, Pérez CE. Valoración del riesgo cardiovascular global y prevalencia de dislipemias según los criterios del NCEP-ATP III en una población adulta de Bogotá, Colombia. Clin Invest Arterioscl 2004;16(3):99-107
20. Escribano Hernández A, Vega Alonso AT, Lozano Alonso JE, Alamo Sanz R, Castrodeza Sanz JJ, Lleras Muñoz S. Dislipidemias y riesgo cardiovascular en la población adulta de Castilla y León (España). Gac Sanit. 2010; 24(4):282-7
21. Feher M, Greener M, Munro N. Persistent hypertriglyceridemia in statin-treated patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2013;6:11-5.
22. Mazza A, Tikhonoff V, Schiavon L, Casiglia E. Triglycerides + high-density- lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly. Intern Med J. 2005;35(10):604-10.
23. Cabrera MA, de Andrade SM, Mesas AE. A prospective study of risk factors for cardiovascular events among the elderly. Clin Interv Aging. 2012;7:463-8.
24. Tóth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006. J Clin Lipidol. 2012;6(4):325-30.
25. Patiño-Villada FA, Arango-Vélez EF, Quintero-Velásquez MA, Arenas-Sosa MM. Factores de riesgo cardiovascular en una población urbana de Colombia. Rev Salud Publica (Bogota). 2011;13(3):433-45.
26. Silva H, Hernandez-Hernandez R, Vinueza R, Velasco M, Boissonnet CP, Escobedo J, et al. Cardiovascular risk awareness, treatment, and control in urban Latin America. Am J Ther. 2010;17(2):159-66.
27. Gotto AM Jr, Moon JE. Management of cardiovascular risk: the importance of meeting lipid targets. Am J Cardiol. 2012;110(1 Suppl):3A-14A.
28. Preis SR, Pencina MJ, Mann DM, D'Agostino RB Sr, Savage PJ, Fox CS. Early-Adulthood Cardiovascular Disease Risk Factor Profiles Among Individuals With and Without Diabetes in the Framingham Heart Study. Diabetes Care. 2013 Jan 22. doi:10.2337/dc12-1121. [Epub ahead of print]